<?xml version="1.0" encoding="windows-1252"?><output><s i="0"><ENAMEX ID="0" TYPE="LOCATION">U.S.</ENAMEX></s>
<s i="1">Judge Declares Mistrial In <ENAMEX ID="1" TYPE="ORGANIZATION">ICN Investors</ENAMEX>' Lawsuit..</s>
<s i="2"><ENAMEX ID="2" TYPE="LOCATION">NEW YORK</ENAMEX> -- A federal court jury here deadlocked on certain claims and rejected others in a class-action lawsuit alleging that <ENAMEX ID="3" TYPE="ORGANIZATION">ICN Pharmaceuticals Inc.</ENAMEX> fraudulently misled investors in 1986 and 1987 about prospects for its <ENAMEX ID="4" TYPE="LOCATION">ribavirin</ENAMEX> drug.</s>
<s i="3">After a five-week trial, <ENAMEX ID="5" TYPE="PERSON">Epstein Welch Ross</ENAMEX> declared a mistrial pertaining to six of the alleged misstatements by the <ENAMEX ID="6" TYPE="LOCATION">Costa Mesa</ENAMEX>, <ENAMEX ID="7" TYPE="LOCATION">Calif.</ENAMEX>, drug company.</s>
<s i="4">Plaintiffs' lawyer <ENAMEX ID="8" TYPE="PERSON">Daniele Alston</ENAMEX> said <ENAMEX ID="8" TYPE="PERSON">Daniele Alston</ENAMEX> will seek a retrial on those issues.</s>
<s i="5">A new trial date hasn't been set.</s>
<s i="6"><ENAMEX ID="9" TYPE="PERSON">Arnold Burns</ENAMEX>, <ENAMEX ID="1" TYPE="ORGANIZATION">ICN Investors</ENAMEX>'s lawyer, said, ``We won outright on seven issues and the remaining six the jury was unable to find for the plaintiff.'' <ENAMEX ID="10" TYPE="PERSON">Mr.</ENAMEX></s>
<s i="7"><ENAMEX ID="8" TYPE="ORGANIZATION">Alston</ENAMEX> disputed an <ENAMEX ID="1" TYPE="ORGANIZATION">ICN Investors</ENAMEX> press release in which the company said the jury findings amounted to a ``vindication.'' The suit, filed in 1987, accused ICN of misleading investors about the effectiveness of its ribavirin drug in patients with AIDS-related conditions.</s>
<s i="8">In <ENAMEX ID="0" TYPE="LOCATION">U.S.</ENAMEX>, the antiviral drug is approved only for treatment of infants hospitalized with infections caused by respiratory syncytial virus.</s>
<s i="9">The plaintiff class includes 7,800 investors whose <ENAMEX ID="1" TYPE="ORGANIZATION">ICN Investors</ENAMEX> shares were purchased between January 1986 and April 1987.</s>
<s i="10">The suit seeks damages equal to the difference between what investors paid for the shares and what their value would have been without the alleged misstatements.</s>
<s i="11">The trial was delayed for various reasons, including the death of a judge appointed to the case.</s>

</output>